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Medical Marijuana and Pain Management: The Physician’s Catch 22
Review Article
James M. McKivigan* 
Abstract
In this paper, concerns connected to the usage of marijuana in treating patients are extensively analyzed. It is 
revealed that physicians have been in conflict with the federal government as to whether to use cannabis for 
medical purposes or if they should consider prescribing other drugs. A large percentage of physicians admit that 
marijuana could be an effective drug in treating patients, especially those with acute pain, nausea, AIDS, muscle 
spasms, and cancer, among other ailments. However, patients and physicians are scared of the strict laws that 
criminalize the use of marijuana for medical and recreational purposes. Physicians are also reluctant to discuss 
the risks of marijuana, even though they might consider recommending it for treatment. The federal government 
criminalized marijuana because it is highly addictive and poses a danger to the health of an individual. Although 
marijuana could be incorporated into treating patients suffering from several medical complications, it is critical 
to support further research that would reveal the guidelines that physicians must follow in ensuring that patients 
benefit from this kind of treatment.
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Medical professionals have presented substantial evidence in 
support of incorporating marijuana in pain management. In 
medical research, the therapeutic benefits of herbal cannabis have 
been noted to be that marijuana has analgesic capabilities, and it 
could be applied in the medication of patients undergoing pain, 
helping them in the recovery process. Also, marijuana could be 
used in relieving anxiety and can effectively treat post-traumatic 
stress disorder, inflammatory bowel complication, and migraines. 
Indeed, some states in the U.S. have enacted legislation that 
allows marijuana to be administered for medical purposes [1]. 
Washington, Colorado, Alaska, and Oregon allow the use of 
marijuana for recreational purposes, and voters in Nevada and 
California have recently voted to permit recreational use as well. 
Perceptions of the laws restricting marijuana use changed when 
these states learned the medicinal value of cannabis sativa. It should 
be noted that the harmful effects of marijuana smoking have been 
well-documented. In fact, this is the reason it has been difficult for 
all states in the U.S. to allow marijuana smoking for recreational 
and medicinal purposes [2]. Nonetheless, medical practitioners 
need to accept that marijuana is an effective drug that could help 
patients undergoing intense pain. Furthermore, several studies 
have documented the usefulness of cannabis in treating cancer 
and other chronic diseases [3]. Additionally, it could be useful in 
treating mania, depression, or both. However, the medical benefits 
have not been comprehensively studied, except the U.S. Food and 
Drug Administration (FDA).
However, the medicinal value of herbal cannabis is accepted 
reluctantly in the United States. In fact, some organizations have 
been fighting against the legalization of marijuana smoking in 
Colorado and Washington, stating that such moves encourage drug 
abuse. 
It should be noted that people who use marijuana face 
stigmatization. In hospitals and rehab centers, it is evident that 
marijuana addicts are struggling to fight off cannabis addiction 
[4]. It is not reasonable for medical personnel to promote a drug 
that would have severe effects if it is not controlled. The intriguing 
question is how cannabis smoking can be regulated, considering 
that it can lead to serious addiction problems. As such, society 
would not embrace the idea of smoking marijuana as a pain reliever 
if it has negative implications such as substance abuse and severe 
mental impairment. In some instances, the use of marijuana has led 
to mental impairment. However, medical research has supported 
the idea that patients who use cannabis mostly experience dry 
mouth and a high. It is essential to note that marijuana smoking 
reduces pain, causes sleep, and keeps a patient in a happy mood. 
However, this can only be possible if marijuana is administered in 
the right dosage [5].
Society expects that an individual should prioritize caring for their 
health and well-being. As such, people should avoid drugs that 
have a negative implication for their health. Considering what has 
been said about marijuana, it does not make sense for physicians to 
support this drug, even though it could be essential for patients in 
pain. An individual who smokes marijuana is equated to someone 
who does not care about his or her well-being. Some patients 
still have to question the effectiveness of cannabis as a medical 
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drug, even though physicians prescribe it for helping patients with 
poor sleeping patterns, bad mood, and pain [6]. For this reason, 
people have been skeptical about using marijuana for medical 
purposes. In fact, some states enacted laws criminalizing smoking 
marijuana. This legislation is necessary to control the health of 
individuals, and substantial fines and heavy sentences are issued to 
people who break these regulations. This situation is the reason it 
has been difficult for physicians to encourage the use of medicinal 
marijuana [7].
It does not bode well with societal expectations, and it sounds 
awkward that people working in hospitals should promote 
marijuana smoking. Smoking marijuana has long been known as 
a crime, and it is punishable in most states in the U.S. Parents in 
the United States have been strict with their children, telling them 
to avoid smoking marijuana [8]. As such, it becomes difficult to 
convince these individuals that smoking marijuana could help them 
in relieving pain. People tend to dwell on the adverse effects of the 
drug, and this has been well-captured in several pieces of literature 
[5].This situation is the reason why administering marijuana as a 
medicinal drug is not widely supported in the United States. The 
United States has instituted laws that criminalize marijuana selling, 
and smoking of the drug in public is prohibited. Some states in the 
United States have legalized the use of marijuana for recreational 
purposes [6]. However, they require nurses in these states to 
understand the laws regarding the prescription of marijuana [3].
Moreover, the United States does not support the idea of using 
marijuana in managing pain among patients, especially those 
in acute care settings. The organization argues that several 
interventions could be better than marijuana. As such, it has 
encouraged physicians to look at the alternatives available, as 
opposed to prescribing marijuana to patients in intense pain. 
The United States has funded several drives against drug abuse. 
Marijuana is always the top drug in these movements because it 
falls among drugs that youths are likely to harm.
Therefore, the aim is to discourage people from smoking 
marijuana and encourage them to stay away from other drugs and 
alcoholic drinks. Because of these actions, it has become difficult 
for people to accept that smoking marijuana is healthy. The U.S. 
government moved with urgency to institute laws to control 
marijuana smoking. The move leaves physicians stranded on 
whether to prescribe marijuana as a pain reliever, even though past 
studies have identified the value of marijuana in controlling pain in 
patients. Experts in the health sector have been reluctant to oppose 
the move by the United States to oppose the use of marijuana. 
In fact, the laws led to the enactment of more stringent laws in 
controlling drug abuse, incorporating the usage of marijuana for 
medical intervention [4].
Some patients have been skeptical concerning the proper dosage of 
marijuana. It poses a difficult situation for physicians in directing 
the required dosage, considering the high chances of overdosing 
on marijuana, which is common in patients. Additionally, no 
federal oversight of purity or content has been identified, meaning 
that people are in the dark regarding the substance of cannabis. In 
fact, questions are raised because many individuals may not know 
the active ingredients of marijuana, and the research has not been 
clear on this topic. There have also been concerns about increased 
clinical availability of herbal cannabis, which could be detrimental 
to the personal health of an individual. It is dangerous for patients 
who may end up fighting an addition of marijuana, especially in 
convincing them that they do not have to smoke the drug after the 
pain has eased. When herbal cannabis is available in pharmacies, 
youths are at risk of abusing this medication. Patients may also 
continue using the drug long after the pain has disappeared, leading 
to additional medical complications [3]. For a drug associated with 
severe medical complications, it becomes difficult to convince 
people that choosing marijuana is the best choice in relieving 
pain in patients. In the past, studies have noted complications 
such as orthostatic hypotension. Another study strongly indicated 
that people who smoke marijuana for one hour are at risk of 
myocardial infarction [1]. It is thus essential for both sides to come 
into agreement, providing detailed recommendations along similar 
lines. For instance, the use of marijuana in relieving pain could 
be effective if more funds are invested in pain-related cannabis 
research [4]. Medical personnel should be involved in the research 
of herbal cannabis, which is possible through the broadening of 
pain conditions, as well as actively participating in increasing 
pain condition research in phase-three trials. Besides, the situation 
could change if regulatory restrictions, which are known to 
impede research, are eliminated. In fact, researchers must consider 
rescheduling the research to schedule one drug. The government 
needs to consider improving access to high-quality cannabis for 
research, enabling diverse strains and derivatives, making it easier 
to determine cannabinoid content ratios. Importantly, states should 
collect individual- and population-level data, as it would make it 
simpler to understand different health outcomes, as well as the 
health implications of using cannabis in pain management.
Currently, most states have not collected individual-level health 
data on the usage of marijuana, including important details 
uncovering how marijuana works. It also provides details on 
unexpected complications, giving reasons why certain medications 
have to be stopped because administering these drugs does 
not have a positive impact on the health of the patient. Argues 
that if medical personnel in the United States were organized 
in researching marijuana, the myths surrounding the harmful 
effects of marijuana would be addressed [9]. Such a study would 
provide important details helping physicians to learn about the 
health impacts of using marijuana. In the past, researchers have 
emphasized that treatment can only be effective if there is quality 
control in the production and dispensing of cannabis. This situation 
is vital in ensuring that medical benefits are not compromised. As 
documented by Wilkinson et al. the legalization of marijuana for 
therapeutic modality requires strict quality control, with the known 
constituents clearly identified. Notably, medication avenues should 
be opened, providing a chance for marijuana to be dispensed by 
pharmacists, in particular, those who acquire medicinal grades of 
cannabis from sources with adequate quality control. Such a move 
would eliminate the blurred lines that exist between therapeutic 
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marijuana and recreational marijuana [4].
The government may come up with legislation that limits physicians 
and patients from using marijuana for medicinal purposes. This 
action is likely to interfere with the relationship between patients 
and doctors. The interaction between the physician and patient 
improves the quality of care accorded to the patients, as doctors 
work on relieving pain in patients. In some cases, the government 
may come up with legislation that guides accepted interventions, 
and in some cases, the government imposes restrictions on the 
medicine that could be used in treating patients [6]. It is expected 
that the dose administered should not be harmful to the patient or 
lead to death.
According to the law, physicians should not be involved in 
activities that may cause harm to the patient. A desirable law is one 
that gives the patient the ability to consent to use marijuana in their 
treatment, especially when the patient deems it fit to ease the pain. 
In the case of an underage patient, the parent should be allowed to 
make the decision on their behalf [10]. The physician’s role is to 
disclose information on marijuana treatment options, advising the 
patient on the right dosage and the right time to use herbal cannabis. 
Previous findings have revealed the advantages of using marijuana 
in easing pain and have also pointed out the negative effects of 
allowing marijuana to be used in treating patients suffering from 
acute pain. Formal drug approval techniques provide physicians 
with the information necessary to form an analysis, putting into 
consideration the risks and benefits for a certain patient, through 
examining issues such as safety and efficiency of the treatment 
offered. In this respect, the biggest concern is not to prohibit 
physicians from administering medicinal marijuana, but rather 
controlling the treatment process to ensure that the drug is not 
misused. Importantly, physicians should demonstrate a willingness 
to provide the essential guidelines for this treatment to the patient 
[1].
In the past, reservations have been posed as to the effectiveness 
of FDA rules in controlling the application of cannabis in treating 
patients. Initially, questions have been raised about the safety 
measures of using marijuana in treating patients. Some scholars 
have argued that the evidence provided regarding the harmful 
effects of drugs is not substantial. However, the adverse effects 
of marijuana have been widely discussed, at the expense of the 
usefulness of this medication in treating patients [8].
The harmful effects of cannabis sativa are widely known, as 
opposed to its usefulness as a medicinal drug. On this account, it 
would be necessary for the FDA to evaluate the risks and benefits 
of using a medication that has been marred by controversy. Indeed, 
the efforts of government officials to frustrate the use of marijuana 
in medical research and the treatment of patients are baffling [2]. 
The government should reconsider its stance because marijuana 
has proven that it could be used in treating cancer patients [6]. 
Besides, HIV/AIDS patients could benefit from marijuana, 
especially patients who have learned of their HIV status and who 
find it hard to accept that they have to accept to live with the 
medical condition. Indeed, the proper use of marijuana is essential 
in the medication process. Given its addictive nature, physicians 
should only prescribe enough drugs to be used in treatment. It is 
proposed that pharmacies should shelve medical marijuana that 
contains codeine and morphine and encourage patients to use these 
drugs according to prescriptions [11].
Even though 40 states have legalized the use of cannabis as 
a medicinal drug, federal laws consider marijuana an illegal 
substance. The federal government regulates illicit drugs through 
the Controlled Substance Act (CSA). The Act does not recognize 
differences between the medical and recreational use of cannabis. 
Instead, individuals who possess, cultivate, or are involved in the 
selling and distribution of marijuana may face prosecution for 
going against the stipulations of the Act.
As documented by Goldsmith et al. marijuana is grouped under 
controlled substances, which means it is similar to drugs such as 
cocaine and heroin. In the United States, the federal government 
classifies drugs in a schedule, and this is based on the potential 
of abusing a particular drug or evaluating its medicinal value. 
The CSA classifies cannabis as a Schedule 1 drug, based on the 
assumption that marijuana is highly addictive and has no medicinal 
value. According to federal laws, doctors should not prescribe 
cannabis for medicinal use [12]. 
Federal cannabis laws are stringent, and individuals found in 
possession of marijuana face a substantial penalty [13]. Federal 
statutes refute the medicinal value of marijuana, claiming that the 
drug is harmful to the health of human beings. In some previous 
rulings, federal judges have insisted that medical issues should 
not be cited as a defense. It should be observed that these laws 
apply to the United States, meaning that these statutes cover states 
such as Colorado, Washington, Oregon, and Alaska. In 2016, 
federal agencies designed guidelines and other policy memoranda, 
significant in managing conflicts between federal and state laws, 
connected to the use of medical marijuana [11].
From 1975 to 1992, the U.S. government worked on legislation 
that would make it easier for patients to use herbal cannabis in 
recuperation from several medical complications. The laws 
approve the use of marijuana for medical and recreational use. 
However, it should be according to the Investigation New Drug 
(IND) program guidelines. Eight U.S. states entered into an 
agreement to legalize the use of medical cannabis, in line with 
the stipulations of IND. However, few patients demonstrated 
willingness to use marijuana for medical purposes. Later, after the 
1970s, the Reagan administration came up with laws that would 
hinder patients from using marijuana for medicinal purposes. 
This action was a game-changer and led to more frustrations in 
the process of accepting marijuana in hospitals. In the recent 
past, the Obama administration claimed that it would not punish 
individuals using marijuana in states that had legalized its use 
for the recreational purpose. On this account, physicians in these 
states were free to prescribe marijuana as a drug that would help 
patients in their recovery processes.
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Other states in the U.S. have used medical necessity as an excuse, 
in a bid to defend themselves whenever they are accused of 
recommending a highly addictive drug to treat patients. Critical 
medication decisions have been made based on these laws, 
considering that the wellness and safety of patients are paramount. 
It should be noted that patients who get marijuana from illegal 
markets, without the recommendation of physicians, should be 
punished [1].
In 1990, marijuana advocates pushed for a referendum that 
would allow legalization of marijuana for medical purposes. This 
consequence is after it was clear that the federal IND program had 
failed in its mandate to control the use of cannabis for treatment. It 
was necessary to work with the citizenry in implementing new laws. 
Following these changes, patients had the freedom to use herbal 
cannabis in managing their medical complications. In the 1966 
referendum, Californians voted for using marijuana in hospital 
setups and in managing pain among patients. Approximately 56% 
of Californian voters were in support of the referendum. As such, 
the state of California had to work with the health care department 
in the state to ensure that the prescription of herbal cannabis is 
safe. In this regard, patients were given the ability to use marijuana 
for medication [3].
A large percentage of physicians claimed that herbal cannabis was 
effective in treating patients experiencing nausea, weight loss, 
pain, and muscle spasms. Furthermore, cannabis sativa would also 
be used in conditions where the patient is seriously ill, and the 
physician deems it fit to administer herbal cannabis. Nonetheless, 
the elaboration on the suitability of this treatment was up to the 
doctor to decide. This way, the doctor would advise the patient 
if it was necessary to incorporate marijuana into their treatment. 
Twenty-three U.S. states enacted laws to allow the medical use of 
the marijuana, legislation that has been in place since 1966. Some 
of the laws on the medicinal use of marijuana have been passed 
through referenda, and others have been affected by legislative 
acts. In California, marijuana was legalized to treat patients with 
different medical complications as long as physicians do not go 
against the stipulated laws. It is critical to remember that the 
legislation on the use of medicinal marijuana is dissimilar across 
different states. Several factors have to be considered before 
marijuana is administered for therapeutic use. Some of the factors 
include the type of illness, how marijuana is acquired from the 
market, and how patients use the drug [1].
It is worth noting that different states have posted different results 
in approving by physicians the use of marijuana. In some states, 
the medicinal use of marijuana is confined to the previous statistics 
on the efficacy of herbal cannabis. The legislation in some states 
limits physicians in using marijuana to managing patients with 
cancer aids and stimulation of appetite. Some states do not have 
limitations on how the doctor uses marijuana for medical purposes. 
As a result, the physician decides if the medical complication 
warrants the prescription of marijuana. In some jurisdictions, the 
physician is required to examine the state of the patient before 
sanctioning the use of marijuana in treatment. It is probable that 
the doctor will advise the patient concerning the risks of using 
marijuana in their treatment [7].
It is argued that the use of herbal cannabis in treatment should 
be done in line with the stipulated guidelines. In administering 
treatment, physicians should ensure that they provide empathetic 
treatment to patients [9]. In other words, physicians need to choose 
an intervention that is not harmful to the life of the patient. In this 
respect, a procedure should be in place to limit the adverse effects 
of using marijuana in managing pain among patients. There is 
no concrete evidence pointing out the efficacy or risks of herbal 
cannabis; it would be ideal for physicians to caution patients about 
the known dangers of using herbal cannabis. The threats posed 
by using marijuana have been widely discussed by scholars [10]. 
Most of these studies have analyzed the adverse effects of smoking 
marijuana for recreational purposes. It would be crucial for patients 
to consent to marijuana treatment. This action should happen after 
physicians have provided comprehensive information to patients, 
to enable them to understand the risks of using herbal cannabis. In 
other words, the administering of herbal cannabis should be in line 
with the physicians’ ethical obligations [9].
It is worth remarking that the scarcity of scientific evidence has 
been a great concern for physicians, and this has led to distress to 
nurses in convincing patients to accept using marijuana in their 
treatment. Some medical practitioners have fears that, in prescribing 
herbal cannabis, it may be difficult to control the medication, and 
it could lead to their prosecution. As Kondrad and Reid point 
out, it is difficult for physicians to monitor the use of marijuana 
for medication, especially for patients who have to recuperate at 
home and in other places far from doctors. Also, it is challenging 
to control addiction problems. This situation is a great concern, 
given the several health risks linked to smoking marijuana, such 
as respiratory complications. Essentially, medical practitioners’ 
recommended therapy should be in line with sound scientific 
study, through outlining the efficacy and safety of marijuana. In 
this respect, before physicians support using herbal cannabis in 
managing pain and other illnesses, described pharmacotherapy 
standards should be met. Presently, doctors administering herbal 
cannabis are yet to fulfill these requirements [7].The absence of 
this crucial knowledge of effective dosing, as well as the lack of 
information on the actual benefits of herbal cannabis, needs to 
be investigated. On this account, proper guidelines should be set 
up outlining a desirable intervention for physicians should they 
recommend marijuana medication.
As Davis et al. discuss, the process can only be effective if 
physicians understand their responsibility in caring for patients. 
This process shows that doctors are more concerned about patients’ 
wellbeing. In the United States, the law stipulates that doctors have 
to accept responsibility for the patients instructed to take herbal 
cannabis. Some states have passed legislation that specifies the 
dosing procedure, duration, and frequency of using marijuana for 
medicinal purposes [10]. It is important that these form the basis of 
therapy, given the fact that marijuana is a drug that could lead other 
medical complications if its use is not monitored. Indeed, patients 
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may not be in a position to control this medication, meaning it 
is essential to work with physicians in ensuring that the adverse 
effects of marijuana smoking do not interfere with treatment. 
The adoption of marijuana in medication, especially in pain 
management, is centered on providing the needed care to patients 
[8]. It is essential to remember that, currently, the sanctioning of 
herbal cannabis for therapy is done by a small percentage of medical 
practitioners in the United States. For instance, in Colorado, only 
15 physicians issued approximately 50% of recommendations, 
which advocate the application of herbal marijuana in treating 
patients in hospitals. Indeed, motives surrounding these medical 
behaviors require further evaluation, considering the ethical issues 
surrounding the use of marijuana for medical purposes. Recently, 
it was revealed that physicians lack confidence in administering 
cannabinoids [7]. Also, these physicians lack the competence 
to advise patients in using herbal marijuana in treating medical 
complications. In Colorado, 19% of physicians recommended 
medical marijuana, whereas 92% claimed that more education is 
necessary to reinforce the skills and competence of physicians. 
Similar studies in Canada documented the declining confidence 
in doctors, after an evaluation of their skills regarding the use of 
medicinal cannabis in hospitals. As such, physicians can bolster 
their confidence if they have a chance to attend a program that 
aims to reinforce their knowledge and competence in incorporating 
marijuana into treatment.
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